Lingxi Nan
Fudan University(CN)Zhongshan Hospital(CN)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Gallbladder and Bile Duct Disorders, Cancer Immunotherapy and Biomarkers, Pediatric Hepatobiliary Diseases and Treatments, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single‐cell RNA sequencing(2021)98 cited
- → Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer(2019)37 cited
- → Prediction Efficacy for Clinical Outcome of Prognostic Nutritional Index in Patients with Resectable Biliary Tract Cancer Depends on Sex and Obstructive Jaundice Status(2020)19 cited
- → Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010‐2016(2019)18 cited
- → Modified staging classification of gallbladder carcinoma on the basis of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system(2019)16 cited
- → High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer(2020)15 cited
- → Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer(2019)14 cited
- → Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients(2021)7 cited
- → ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer(2022)7 cited
- → 3D laparoscopic common bile duct exploration versus 2D in choledocholithiasis patients: a propensity score analysis(2020)5 cited